Connor Clark & Lunn Investment Management Ltd. purchased a new position in National Health Investors, Inc. (NYSE:NHI – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,355 shares of the real estate investment trust’s stock, valued at approximately $282,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in NHI. Aviance Capital Partners LLC boosted its stake in National Health Investors by 6.2% in the third quarter. Aviance Capital Partners LLC now owns 3,788 shares of the real estate investment trust’s stock worth $318,000 after purchasing an additional 221 shares in the last quarter. Quest Partners LLC acquired a new position in National Health Investors during the 3rd quarter worth about $230,000. Thrivent Financial for Lutherans acquired a new position in National Health Investors during the 3rd quarter worth about $2,426,000. Metis Global Partners LLC grew its holdings in National Health Investors by 31.2% during the 3rd quarter. Metis Global Partners LLC now owns 4,474 shares of the real estate investment trust’s stock worth $376,000 after acquiring an additional 1,065 shares during the last quarter. Finally, Pinnacle Financial Partners Inc increased its position in National Health Investors by 7.7% in the 3rd quarter. Pinnacle Financial Partners Inc now owns 49,488 shares of the real estate investment trust’s stock valued at $4,160,000 after acquiring an additional 3,546 shares in the last quarter. Institutional investors own 62.51% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on NHI. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Truist Financial upped their price target on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, August 30th. Finally, Bank of America initiated coverage on National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective for the company. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors presently has a consensus rating of “Moderate Buy” and an average target price of $76.33.
National Health Investors Trading Down 0.3 %
Shares of NYSE:NHI opened at $76.65 on Monday. National Health Investors, Inc. has a 12-month low of $51.59 and a 12-month high of $86.13. The business has a 50 day moving average of $78.75 and a 200-day moving average of $74.82. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock has a market cap of $3.48 billion, a PE ratio of 26.34, a P/E/G ratio of 5.12 and a beta of 1.05.
National Health Investors (NYSE:NHI – Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The company had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. National Health Investors’s revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the business earned $1.08 EPS. As a group, equities research analysts forecast that National Health Investors, Inc. will post 4.42 earnings per share for the current year.
National Health Investors Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.70%. National Health Investors’s payout ratio is presently 123.71%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories
- Five stocks we like better than National Health Investors
- Using the MarketBeat Dividend Tax Calculator
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What is a Death Cross in Stocks?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- The 3 Best Blue-Chip Stocks to Buy Now
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.